Rapp M - Search Results

1

A new O6-alkylguanine-DNA alkyltransferase inhibitor associated with a nitrosourea (cystemustine) validates a strategy of melanoma-targeted therapy in murine B16 and human-resistant M4Beu melanoma xenograft models.

Rapp M, Maurizis JC, Papon J, Labarre P, Wu TD, Croisy A, Guerquin-Kern JL, Madelmont JC, Mounetou E. Rapp M, et al. J Pharmacol Exp Ther. 2008 Jul;326(1):171-7. doi: 10.1124/jpet.108.137737. Epub 2008 Apr 14. J Pharmacol Exp Ther. 2008. PMID: 18411412

2

Enhancement by O6-benzyl-N-acetylguanosine derivatives of chloroethylnitrosourea antitumor action in chloroethylnitrosourea-resistant human malignant melanocytes.

Cussac C, Rapp M, Mounetou E, Madelmont JC, Maurizis JC, Godeneche D, Dupuy JM, Sauzieres J, Baudry JP, Veyre A. Cussac C, et al. Among authors: rapp m. J Pharmacol Exp Ther. 1994 Dec;271(3):1353-8. J Pharmacol Exp Ther. 1994. PMID: 7996446

3

Enhancement by O6-benzyl-N2-acetylguanosine of N'-[2-chloroethyl]-N-[2-(methylsulphonyl)ethyl]-N'-nitrosourea therapeutic index on nude mice bearing resistant human melanoma.

Debiton E, Cussac-Buchdhal C, Mounetou E, Rapp M, Dupuy JM, Maurizis JC, Veyre A, Madelmont JC. Debiton E, et al. Among authors: rapp m. Br J Cancer. 1997;76(9):1157-62. doi: 10.1038/bjc.1997.527. Br J Cancer. 1997. PMID: 9365163 Free PMC article.

4

Synthesis, radiosynthesis, and biological evaluation of new proteasome inhibitors in a tumor targeting approach.

Vivier M, Rapp M, Papon J, Labarre P, Galmier MJ, Sauzière J, Madelmont JC. Vivier M, et al. Among authors: rapp m. J Med Chem. 2008 Feb 28;51(4):1043-7. doi: 10.1021/jm701419g. Epub 2008 Feb 1. J Med Chem. 2008. PMID: 18237109

5

DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells.

Godeneche D, Rapp M, Thierry A, Laval F, Madelmont JC, Chollet P, Veyre A. Godeneche D, et al. Among authors: rapp m. Cancer Res. 1990 Sep 15;50(18):5898-903. Cancer Res. 1990. PMID: 2393861

6

Disposition and metabolism of O6-alkylguanine-DNA alkyltransferase inhibitor in nude mice bearing human melanoma.

Cussac C, Mounetou E, Rapp M, Madelmont JC, Maurizis JC, Labarre P, Chollet P, Chabard JL, Godeneche D, Baudry JP, et al. Cussac C, et al. Among authors: rapp m. Drug Metab Dispos. 1994 Jul-Aug;22(4):637-42. Drug Metab Dispos. 1994. PMID: 7956741

7

Synthesis and pharmacokinetic profile of a quaternary ammonium derivative of chlorambucil, a potential anticancer drug for the chemotherapy of chondrosarcoma.

Rapp M, Giraud I, Maurizis JC, Madelmont JC. Rapp M, et al. Bioorg Med Chem. 2003 Nov 17;11(23):5007-12. doi: 10.1016/j.bmc.2003.09.006. Bioorg Med Chem. 2003. PMID: 14604663

8

Main urinary metabolites of two cysteamine-containing 2-(chloroethyl) nitrosoureas in rats.

Godeneche D, Labarre P, Moreau MF, Madelmont JC, Rapp M, Papon J, Veyre A. Godeneche D, et al. Among authors: rapp m. Drug Metab Dispos. 1993 Jan-Feb;21(1):93-9. Drug Metab Dispos. 1993. PMID: 8095233

9

Application to a cartilage targeting strategy: synthesis and in vivo biodistribution of (14)C-labeled quaternary ammonium-glucosamine conjugates.

Giraud I, Rapp M, Maurizis JC, Madelmont JC. Giraud I, et al. Among authors: rapp m. Bioconjug Chem. 2000 Mar-Apr;11(2):212-8. doi: 10.1021/bc990128+. Bioconjug Chem. 2000. PMID: 10725098

10

New quaternary ammonium oxicam derivatives targeted toward cartilage: synthesis, pharmacokinetic studies, and antiinflammatory potency.

Nicolas C, Verny M, Giraud I, Ollier M, Rapp M, Maurizis JC, Madelmont JC. Nicolas C, et al. Among authors: rapp m. J Med Chem. 1999 Dec 16;42(25):5235-40. doi: 10.1021/jm991120o. J Med Chem. 1999. PMID: 10602708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

840 results

Search Page

Filters